Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-008579
Filing Date
2022-03-02
Accepted
2022-03-02 16:05:32
Documents
2
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1622
2 EX-24 DOCUMENT attachment1.htm EX-24 4799
  Complete submission text file 0000899243-22-008579.txt   7814
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Issuer) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CHECKMATE PAHRMACEUTICALS, INC. 245 MAIN STREET 2ND FLOOR CAMBRIDGE MA 02142
Business Address
BASH ALAN (Reporting) CIK: 0001908421 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39425 | Film No.: 22703380